References
- Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. Bcl-x, a Bcl-2-relatedgene that functions as a dominant regulator of apoptotic death. Cell 74:597–608.
- Boise, L. H., and C. B. Thompson. 1997. Bcl-xL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94:3759–3764.
- Boyd, J. M. et al. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival proteins. Oncogene 11:1921–1928.
- Chang, B. S., A. J. Minn, S. W. Muchmore, S. W. Fesik, and C. B. Thompson. 1997. Identification of a novel regulatory domain in Bcl-xL and Bcl-2. EMBO J. 16:968–977.
- Chen, G., P. E. Branton, E. Yang, S. J. Korsmeyer, and G. C. Shore. 1996. Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271:24221–24225.
- Cheng, E. H.-Y., B. Levine, L. H. Boise, C. B. Thompson, and J. M. Hardwick. 1996. Bax-independent inhibition of apoptosis by Bcl-xL. Nature (London) 379:554–556.
- Chittenden, T., C. Flemington, A. B. Houghton, R. G. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz. 1995. A conserved domain in Bak, distinct from BH1 and BH2 mediates cell death and protein binding functions. EMBO J. 14:5589–5596.
- Chittenden, T., E. A. Harrington, R. O’Connor, C. Flemington, R. J. Lutz, G. I. Evan, and B. C. Guild. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (London) 374:733–736.
- Erlich, H. A. 1989. PCR technology—principles and applications for DNA amplification. Stockton Press, New York, N.Y.
- Farrow, S. N., and R. Brown. 1996. New members of the Bcl-2 family and their protein partners. Curr. Opin. Gen. Dev. 6:45–49.
- Gibson, L., S. P. Holmgreen, D. C. Huang, O. Bernard, N. G. Copeland, N. A. Jenkins, G. R. Sutherland, E. Baker, J. M. Adams, and S. Cory. 1996. Bcl-w, a novel member of the Bcl-2 family, promotes cell survival. Oncogene 13:665–675.
- Han, J., P. Sabbatini, D. Perez, P. Rao, D. Modha, and E. White. 1996. The E1B 19K protein functions as an apoptosis inhibitor by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:461–477.
- Han, J., P. Sabbatini, and E. White. 1996. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:5857–5864.
- Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homolog of Bcl-2 protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479–8483.
- Hengartner, M. O., R. E. Ellis, and H. R. Horvitz. 1992. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature (London) 356:494–499.
- Hengartner, M. O., and H. R. Horvitz. 1994. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665–676.
- Hockenberry, D., G. Nunez, C. L. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 377:695–701.
- Hunter, J. J., and T. G. Parslow. 1996. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271:8521–8524.
- Kiefer, M. C., M. J. Brauer, V. C. Powers, J. J. Wu, S. R. Umansky, L. D. Tomei, and P. J. Barr. 1995. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (London) 374:736–739.
- Kozopas, K. M., T. Yang, H. L. Buchan, P. Zhou, and R. W. Craig. 1993. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc. Natl. Acad. Sci. USA 90:3516–3520.
- Minn, A. J., L. H. Boise, and C. B. Thompson. 1996. Bcl-xS antagonizes the protective effects of Bcl-xL. J. Biol. Chem. 271:6306–6312.
- Minn, A. J., L. H. Boise, and C. B. Thompson. 1996. Expression of Bcl-xL can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10:2621–2631.
- Muchmore, S. W. et al. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (London) 381:335–341.
- Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619.
- Rao, L., M. Debbas, P. Sabbatini, D. Hockenberry, S. J. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742–7746.
- Sattler, M. et al. 1997. Structure of Bcl-xL/Bax peptide complex: recognition between regulators of apoptosis. Science 275:983–986.
- Sato, T. et al. 1994. Interactions among members of the Bcl-2 family analyzed with a yeast 2-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238–9242.
- Sedlak, T. W., Z. N. Oltvai, E. Yang, K. Wang, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer. 1995. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92:7834–7838.
- Shaham, S., and H. R. Horvitz. 1996. An alternatively spliced C. elegans Ced-4 RNA encodes a novel cell death inhibitor. Cell 86:201–208.
- Shibasaki, F., E. Kondo, T. Akagi, and F. McKeon. 1997. Suppression of signalling through NF-AT by interactions between calcineurin and Bcl-2. Nature (London) 386:728–731.
- Vaux, D. L., S. Cory, and T. M. Adams. 1988. Bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature (London) 335:440–442.
- Wang, H. G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629–638.
- Wang, K., X.-M. Yin, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859–2869.
- White, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:2570–2580.
- Yang, E., J. Zha, E., J. Jockel, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer. 1995. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285–291.
- Yin, X.-M., Z. Oltvai, and S. J. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (London) 369:321–323.
- Zamzami, N. et al. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:367–377.
- Zha, H., C. Aime-Sempe, T. Sato, and J. C. Reed. 1996. Pro-apoptotic protein, Bax, heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3), distinct from BH1 and BH2. J. Biol. Chem. 271:7440–7444.
- Zha, J., H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-XL. Cell 87:619–628.